|
|
|
   
|
Press releases„As of November 1, 2007, all the assets of CPC, Inc. including the CYTOS brand have been aquired by YMC, Co., Ltd., Kyoto, Japan (ymc.co.jp)“All the references to be directed to: "Synthacon sold to ICIG"Mainz, Germany, December 22, 2006. CPC-Systems informs, that Synthacon (www.synthacon.biz) was aquired to 100% from International Chemical Investors Group (ICIG; www.ic-investors.com). Synthacon was founded as joint venture from ProBioGen and CPC-Systems in 2003. With this aquisition from ICIG, Synthacon is now member of a group of chemical companies, which supports the application of CPC-Systems' microreaction technology by expanding Synthacons sales and marketing operations by the other group members. Synthacon is the customer of CPC-Systems with the most running CYTOS® microreaction systems and of course our traditional close collaboration will be continued. Joint project between CPC-Systems and Cologne University receives funding approvalFrankfurt/Main, Germany, June 1, 2002. The German Ministry for Research and Education (BMBF) has approved a joint project between CPC — Cellular Process Chemistry Systems GmbH and the research group led by Prof. Dr. Hans-Jürgen Schmalz at the University of Cologne. The object of this project is to explore, in detail, the potential of microreactors in the field of chemical synthesis and to examine the possibility for new applications of this technology. The project will also contribute towards the establishment of this technology in academic research as well as the chemical industry. The project will focus on organometallic reactions and homogenous catalysis to improve the efficiency and selectiveness of industrial related processes and to evaluate the scope of this technology for commercial production of speciality chemicals. Associated partners in this project are the Vitamins & Fine Chemicals division of Hoffmann-La Roche, Basel, Switzerland, and Chemetall GmbH, Frankfurt, Germany. German Federal Environment Foundation approves Project "Environmentally Friendly Production with Microreaction Technology"Frankfurt/Main, Germany, June 1, 2002. Environmental Advantages of production processes based on microreaction technology over conventional batch processes, are the focus of a new project of CPC - Cellular Process Chemistry Systems GmbH and partners from academia and industry. An industrially relevant batch production process will be transferred to a continuous process using microreactors, and the environmental impact of both processes will be compared using an ecological balance sheet. CPC-Systems GmbH, as the lead associate, and its partners—the Institute for Technical Chemistry and Environmental Chemistry, Jena University, and Bayer AG, (both from Germany)—will work closely together to provide a solution to an environmentally relevant challenge. In the course of this project, CPC-Systems GmbH will demonstrate the technical feasibility of a process provided by Bayer AG for microreactors, and will build a production pilot plant based on a parallelized microreactor array. The University of Jena will analyse the benefits and added value of microreaction technology over the batch process, and will evaluate the end product based on environmental criteria. Progress in Transferring Microreactors from the Lab into Production—an Example in the Field of Pigments TechnologyFrankfurt/Main, Germany, May 27, 2002. CPC — Cellular Process Chemistry Systems GmbH and Clariant AG have successfully engineered the transfer of a three-step pigment synthesis into a continuously operating pilot production plant with multi-ton production capacity. This important accomplishment underlines the importance of CPC-Systems GmbH breathtaking technology for commercial production quantities and has proven the unique "numbering-up" concept. The process used, produces the pigments as solids that precipitate during the reaction. Thus, two challenges had to be looked at: a) Can a continuously operating microreaction system handle the resulting suspension in a reliable way and b) Can the microreactor influence the two most important quality drivers, crystal size distribution and colourimetric qualities? Early experiments demonstrated that both challenges have been successfully met and that the new product possesses a sharper, and better defined, crystal size distribution and significantly improved colourimetric qualities (brightness, transparency, colour strength). This result triggered the design, engineering, procurement, installation and commissioning of a pilot production plant to explore the viability of a multi-ton pilot production scale unit. It has been shown that not only can the laboratory experiments be successfully reproduced, but also that potential problems such as fouling or clogging can be successfully overcome. Strategic development collaboration between GlaxoSmithkline and CPC-Systems signedMainz, Germany, February 15, 2002. CPC—Cellular Process Chemistry Systems GmbH (CPC-Systems) today announces the signing of a strategic development collaboration to demonstrate proof of concept for the conversion of a traditional batch synthesis into a multi-step, continuously operated microreaction plant. Under terms of the agreement, CPC-Systems will design, construct and implement an integrated continuous production system based on its own microreaction technology expertise and intellectual property over the next 2 1/2 years. In return, CPC-Systems will receive milestone and research payments. Further details are not disclosed. "We see this agreement as a critical step in the evolution of CPC-Systems. It provides us with an opportunity to fully explore the potential of our unique technology approach in conjunction with a world class pharmaceutical company," says Dr. Thomas Schwalbe, CEO of CPC-Systems. Microreaction technology leads to a paradigm shift by demonstrating the advantages of continuous processing over batch processing, from bench to production scale. Contrary to batch processing, where large volumes have to be handled, continuous processing means steady-state operating conditions in small hold-up volumes with increased control and safety. Access to large quantities is given by parallelization of microreactor modules: numbering-up instead of scale-up. This new methodology generates a significant increase in research and development throughput. CPC-Systems, with its innovative technology, represents an opportunity for the rationalization of drug development processes. Its value for the life science industry is tremendous leading to a significant impact on R&D throughput and manufacturing quality. CPC Systems' technology with its CYTOS® microreactor centrepiece enables life science industries to achieve step-growth in chemical research and development throughput as well as in operational flexibility in manufacturing. CPC—Cellular Process Chemistry Systems GmbH is a rapidly growing company engaged in the design and fabrication of integrated microreaction systems and their applications to chemical processes from research to production quantities. CPC-Systems was founded in Germany in February 1999. Today, CPC-Systems has two facilities in Mainz and Frankfurt, both in Germany and is the market leader in microreaction technology. CPC-Systems supports CPAC- Microreactor-PlatformJanuary 7, 2002. CPC-Systems has joined the CPAC consortium and will support CPAC's research initiative for developing of analytical sensing technologies by applying microreaction technology. The Center for Process Analytical Chemistry (CPAC) is a cooperative venture between the University of Washington, international industrial sponsors incorporated in the U.S., several national laboratories, and other government agencies. CPC-Systems is an innovative company engaged in designing and fabrication of modular standard microreaction systems and its application in organic synthesis. The CPAC Micro-Reactor Initiative focuses on the operation of commercially available micro-reactor systems as test beds for the testing and development of analytical sensing technologies and process control issues. CPAC also envisions the platform as a valuable educational tool in the chemistry and chemical engineering disciplines, particularly as part of the engineering unit operations laboratory section of chemical engineering. Microreactor technology offers the possibility to approach true process conditions that are generally not available in academic setting, mentioned Dr. Mel Koch, president of CPAC. He added, with the CPC standard system, CYTOS® microreaction system, and CPC experiences in the area of microreaction technology CPAC can start right from the beginning with a competent partner and professional equipment. Dr. Thomas Schwalbe (CPC-Systems, CEO) pointed that CPAC research purposes in the field of microreaction technology is an excellent opportunity for CPC-Systems to discuss different challenging opportunities of this cutting edge technology in a efficient consortium with industrial and academic contributions. CPC has developed its first gas-liquid microreactor with production capacityFrankfurt/Main, Germany, 28th September 2000. Only a few weeks after the product launch of CYTOS® Lab System, the world's first modular microreaction system build in series, CPC today announced the setup of its new designed gas-liquid microreactor. The gas-liquid microreactor is designed for the production of aggressive agents. It offers a yearly throughput in the mid ton-range under extreme operating conditions such as high temperature and pressure. For higher production quantities the system could be parallelized easily. CPC demonstrates the new system to further potential customers in Germany within the next weeks. For more information please contact us at info@cpc-net.com |
| | ||||
 |
||||
|